Unknown OBSERVATIONAL NCT04352712

Gene Expression in Monocytes of Growth Hormone Deficient Children (GEMGH)

Growth Hormone Modulated Gene Expression in Monocytes of Healthy and Growth Hormone Deficient Children

Sponsor: University of Salerno

Updated 6 times since 2020 Last updated: May 12, 2020 Started: Apr 15, 2019 Primary completion: Apr 15, 2021 Completion: Apr 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Growth Hormone Deficiency and is currently ongoing. University of Salerno leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — May 2022 [monthly]

Recruiting
Jun 2020 — Jan 2021 [monthly]

Recruiting

▶ Show 1 earlier version

May 2020 — Jun 2020 [monthly]

Recruiting

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Salerno

Data source: University of Salerno

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baronissi, Italy